Inhibitory control is related to fecal short-chain fatty acid concentrations in adults with overweight and obesity
Nutrition Research · 2025
DOI: 10.1016/j.nutres.2025.03.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition Research, 2025. Verfasst von Nathaniel B Willis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nutrition Sciences, University of Illinois Urbana-Champaign, Urbana, IL USA. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Feces, Obesity, Overweight. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Hass Avocado Board, National Institute of Food and Agriculture.
Abstract (Originalsprache)
Obesity is a pro-inflammatory condition with negative effects on executive functioning. Increased inflammation dysregulates gastrointestinal homeostasis and alters microbiota community composition. The gut microbiota produce immunomodulatory short-chain fatty acids (SCFA) that have been related to cognition in obesity, but the neural effects are not explored. Here, we hypothesized that greater fecal SCFA would be positively related to neuroelectric markers of inhibitory control and conflict monitoring in obesity. A cross-sectional cohort of 87 adults (35 ± 6 years, 53 females) with overweight and obesity (BMI = 32 ± 6 kg/m2) provided fresh fecal samples and participated in cognitive testing to assess response inhibition and conflict monitoring with electroencephalographic recording. Linear regressions, controlling for age, sex, BMI, and energy-adjusted dietary fiber intake, revealed positive relationships between NoGo N2 mean amplitude and fecal SCFA concentrations. Linear discriminant analysis effect size (LEfSe) revealed 16 amplicon sequence variants differentially abundant between high and low butyrate groups with Roseburia and Adlercreutzia individually related to NoGo N2 mean amplitude in MaAsLin2 modeling. Thus, greater fecal SCFA concentrations and SCFA producing microbiota (i.e., Roseburia) were related to markers of superior conflict monitoring in the NoGo task when adjusting for key covariates. These data highlight key associations between bacterial derived gut signaling molecules and neural regulation in cognitive domains particularly relevant to weight status that warrant further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nutrition Sciences, University of Illinois Urbana-Champaign, Urbana, IL USA.
- Department of Health and Kinesiology, University of Illinois Urbana-Champaign, Urbana, IL USA.
- Department of Psychology, Eastern Illinois University, Charleston, IL USA.
- Division of Nutrition Sciences, University of Illinois Urbana-Champaign, Urbana, IL USA; Department of Health and Kinesiology, University of Illinois Urbana-Champaign, Urbana, IL USA; Department of Food Science and Huma…
- Division of Nutrition Sciences, University of Illinois Urbana-Champaign, Urbana, IL USA; Department of Health and Kinesiology, University of Illinois Urbana-Champaign, Urbana, IL USA; Neuroscience Program, University of…
Förderung
- Hass Avocado Board
- National Institute of Food and Agriculture
Zitieren
APA
Willis, N. B., Cannavale, C. N., Walk, A. M., Burd, N. A., Holscher, H. D., & Khan, N. A. (2025). Inhibitory control is related to fecal short-chain fatty acid concentrations in adults with overweight and obesity. Nutrition Research. https://doi.org/10.1016/j.nutres.2025.03.006
Vancouver
Willis NB, Cannavale CN, Walk AM, Burd NA, Holscher HD, Khan NA. Inhibitory control is related to fecal short-chain fatty acid concentrations in adults with overweight and obesity. Nutrition Research. 2025. doi:10.1016/j.nutres.2025.03.006
BibTeX
@article{Willis2025,
author = {Willis, Nathaniel B and Cannavale, Corinne N and Walk, Anne M and Burd, Nicholas A and Holscher, Hannah D and Khan, Naiman A},
title = {Inhibitory control is related to fecal short-chain fatty acid concentrations in adults with overweight and obesity},
journal = {Nutrition Research},
year = {2025},
doi = {10.1016/j.nutres.2025.03.006}
}
EUVIMED